Ticker: AUTL

11:56am, Monday, Dec 29, 2025

Autolus Therapeutics Soars as Needham Lifts Price Target on Strong Aucatzyl Sales

Autolus Therapeutics (NASDAQ:AUTL) rallies over 8% following Needham's price target bump to $11, driven by robust Aucatzyl sales and upcoming clinical catalysts set for 2026.